Taskforce takes aim at CPAP sales process

The MBS Review Taskforce is taking aim at corporate sleep testing clinics that sell patients expensive CPAP devices without them ever being seen by a specialist.

In its review of sleep study MBS items, a taskforce committee identified a small number of medical corporates with a high volume of claims for home-based sleep investigations for obstructive sleep apnoea (OSA).

It found 67% of patients who had a home-based sleep investigation for OSA did not have a consultation with a sleep specialist 12 months before or after the investigation.

The committee’s report said there had been a blowout in MBS claims for  home-based sleep investigations, and that patients were being referred to “sleep disorder businesses” for the investigations by GPs using pro-forma online referral forms.

The committee noted with concern that input from